Thomas Powles

41PUBLICATIONS
325CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

|Mar 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.

Francesca Jackson-Spence, James Larkin, Poulam Patel

|Jan 15, 2026
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study.

Yohann Loriot, Thomas Powles, Victor Moreno

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Oct 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.

Thomas Powles, Aarti Bhatia, Barbara Burtness

|Aug 15, 2025
Treatment Optimization and Management of AEs with Enfortumab Vedotin + Pembrolizumab for Untreated Locally Advanced/Metastatic Urothelial Cancer: A Podcast.

Thomas Powles, Maria Lapuente, Benjamin Garmezy

Pageof 7

Frequent Collaborators

5 joint publications

Petros Grivas

5 joint publications

Yohann Loriot

5 joint publications

Joaquim Bellmunt

5 joint publications

Maria Jose Mendez-Vidal